Get started
Author

Yunxin Y. Bo

Enantioselective Total Synthesis of Aspidophytine
1999 · Feng He, Yunxin Bo, et al. · Journal of the American Chemical Society · 225
Highly Enantioselective Phase Transfer Catalyzed Alkylation of a 3-Oxygenated Propionic Ester Equivalent; Applications and Mechanism
1998 · E. J. Corey, Yunxin Bo, et al. · Journal of the American Chemical Society · 154
Discovery of Potent, Orally Available Vanilloid Receptor-1 Antagonists. Structure−Activity Relationship of N-Aryl Cinnamides
2004 · Elizabeth M. Doherty, Christopher Fotsch, et al. · Journal of Medicinal Chemistry · 104
Novel Vanilloid Receptor-1 Antagonists: 2. Structure−Activity Relationships of 4-Oxopyrimidines Leading to the Selection of a Clinical Candidate
2007 · Elizabeth M. Doherty, Christopher Fotsch, et al. · Journal of Medicinal Chemistry · 100
Design of Potent, Orally Available Antagonists of the Transient Receptor Potential Vanilloid 1. Structure−Activity Relationships of 2-Piperazin-1-yl-1H-benzimidazoles
2006 · Vassil I. Ognyanov, Chenera Balan, et al. · Journal of Medicinal Chemistry · 86
Phospshoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors: Discovery and Structure–Activity Relationships of a Series of Quinoline and Quinoxaline Derivatives
2011 · Nobuko Nishimura, Aaron Siegmund, et al. · Journal of Medicinal Chemistry · 61
Fused Piperidines as a Novel Class of Potent and Orally Available Transient Receptor Potential Melastatin Type 8 (TRPM8) Antagonists
2012 · Nuria A. Tamayo, Yunxin Bo, et al. · Journal of Medicinal Chemistry · 56
Structure-Based Design of a Novel Series of Potent, Selective Inhibitors of the Class I Phosphatidylinositol 3-Kinases
2012 · Adrian L. Smith, Noel D. D’Angelo, et al. · Journal of Medicinal Chemistry · 51
Selective Class I Phosphoinositide 3-Kinase Inhibitors: Optimization of a Series of Pyridyltriazines Leading to the Identification of a Clinical Candidate, AMG 511
2012 · Mark H. Norman, Kristin L. Andrews, et al. · Journal of Medicinal Chemistry · 49
Optimization of Potency and Pharmacokinetic Properties of Tetrahydroisoquinoline Transient Receptor Potential Melastatin 8 (TRPM8) Antagonists
2014 · Daniel B. Horne, Nuria A. Tamayo, et al. · Journal of Medicinal Chemistry · 45
New, practical and effective sources of fluoride ion for desilylation to form carbon anions
1999 · Jakob Busch-Petersen, Yunxin Bo, et al. · Tetrahedron Letters · 45
Novel Vanilloid Receptor-1 Antagonists: 1. Conformationally Restricted Analogues oftrans-Cinnamides
2007 · Mark H. Norman, Jiawang Zhu, et al. · Journal of Medicinal Chemistry · 44
Synthesis of (±)-Calicheamicinone by Two Related Methods
1996 · D. L. J. Clive, Yunxin Bo, et al. · Journal of the American Chemical Society · 35
Synthesis of Heterocycles by Tandem Reactions: Beckmann Rearrangements/Allylsilane Cyclizations
1991 · Dieter Schinzer, Yunxin Bo · Angewandte Chemie International Edition in English · 34
Synthetic studies on calicheamicin γ1I—synthesis of(−)-calicheamicinone and models representing the four sugars and the aromatic system
2000 · Derrick L. J. Clive, Yong Tao, et al. · Chemical Communications · 31
Small Molecule Disruptors of the Glucokinase–Glucokinase Regulatory Protein Interaction: 5. A Novel Aryl Sulfone Series, Optimization Through Conformational Analysis
2015 · Nuria A. Tamayo, Mark H. Norman, et al. · Journal of Medicinal Chemistry · 30
Synthesis and structure–activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1,3,5-triazine sulfonamide scaffold
2012 · Ryan P. Wurz, Longbin Liu, et al. · Bioorganic & Medicinal Chemistry Letters · 30
Synthesis and evaluation of thiazole carboxamides as vanilloid receptor 1 (TRPV1) antagonists
2005 · Ning Xi, Yunxin Bo, et al. · Bioorganic & Medicinal Chemistry Letters · 27
Synthesis and X-ray crystal structure of (?)-calicheamicinone
1999 · Derrick L.J. Clive, Yunxin Bo, et al. · Tetrahedron · 25
Synthesis of (±)-Calicheamicinone by Two Methods
1998 · Derrick L. J. Clive, Yunxin Bo, et al. · Journal of the American Chemical Society · 24
The imidazo[1,2-a]pyridine ring system as a scaffold for potent dual phosphoinositide-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitors
2015 · Markian M. Stec, Kristin L. Andrews, et al. · Bioorganic & Medicinal Chemistry Letters · 21
Discovery of N-(3,5-bis(1-pyrrolidylmethyl)-4-hydroxybenzyl)-4-methoxybenzenesulfamide (sulcardine) as a novel anti-arrhythmic agent
2012 · Dong-lu Bai, Wei-zhou Chen, et al. · Acta Pharmacologica Sinica · 21
PDF
Melanocortin subtype-4 receptor agonists containing a piperazine core with substituted aryl sulfonamides
2005 · Christopher Fotsch, Nianhe Han, et al. · Bioorganic & Medicinal Chemistry Letters · 19
Synthese von Heterocyclen durch Tandem‐reaktionen: Beckmann‐Umlagerungen/Allylsilan‐Cyclisierungen
1991 · Dieter Schinzer, Yunxin Bo · Angewandte Chemie · 12
Substituted aryl pyrimidines as potent and soluble TRPV1 antagonists
2008 · Markian M. Stec, Yunxin Bo, et al. · Bioorganic & Medicinal Chemistry Letters · 11
Works count: 33
Citation count: 1,355
H-index: 21
I10-index: 26
Year
Topic
Type